The Genus Yersinia pp 376-386

Part of the Advances In Experimental Medicine And Biology book series (AEMB, volume 603) | Cite as

Cell-Mediated Defense Against Yersinia pestis Infection

  • Stephen T. Smiley
Chapter

Yersinia pestis (Yp) - one of the world’s most deadly human pathogens - is the gram-negative bacterium that causes pneumonic plague. Virulent antibiotic-resistant Yp strains exist and Cold War scientists devised means to effectively aerosolize Yp. These facts raise grave concern that Yp will be exploited as a bioweapon. To counter that possibility, it is essential that we develop a safe and effective pneumonic plague vaccine. Recent studies suggest that the leading vaccine candidate, which primarily stimulates antibody-mediated humoral immunity, may not suffice. T cell-dependent cellular immunity comprises a second means by which vaccines prime long-lived protection against virulent bacterial pathogens. However, a plasmid carried by virulent Yp encodes factors that dampen inflammation and debilitate phagocytes, thereby compromising cellular defense mechanisms. As such, plague vaccine researchers have devoted relatively little attention to cellular immunity. Here we review our recent work demonstrating that the passive transfer of primed T cells can suffice to protect mice against lethal intranasal Yp infection, a model of pneumonic plague. We also demonstrate that key elements of cellular immunity even play critical roles during antibody-mediated defense against plague. We conclude that next-generation plague vaccines should strive to prime both cellular and humoral immunity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

35.8 References

  1. Alibek, K. (1999) Biohazard. Random House, Inc., New York.Google Scholar
  2. Anderson, G.W., Jr., Heath, D.G., Bolt, C.R., Welkos, S.L. and Friedlander, A.M. (1998) Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58, 793-799.PubMedGoogle Scholar
  3. Brubaker, R.R. (2000) Yersinia pestis and bubonic plague. In The prokaryotes, an evolving electronic resource for the microbiological community. Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.-H., and Stackebrandte, E. (eds.) Springer-Verlag, New York, http://141.150.157.117:8080/prokPUB/chaprender/jsp/showchap.jsp?chapnum=265.
  4. Brubaker, R.R. (2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71, 3673-3681.CrossRefPubMedGoogle Scholar
  5. Cowan, C., Philipovskiy, A.V., Wulff-Strobel, C.R., Ye, Z. and Straley, S.C. (2005) Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect. Immun. 73, 6127-6137.CrossRefPubMedGoogle Scholar
  6. Croft, M. (1994) Activation of naive, memory and effector T cells. Curr. Opin. Immunol. 6, 431-437.CrossRefPubMedGoogle Scholar
  7. Friedlander, A.M., Welkos, S.L., Worsham, P.L., Andrews, G.P., Heath, D.G., Anderson, G.W., Jr., Pitt, M.L., Estep, J. and Davis, K. (1995) Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21 Suppl 2, S178-181.Google Scholar
  8. Galimand, M., Guiyoule, A., Gerbaud, G., Rasoamanana, B., Chanteau, S., Carniel, E. and Courvalin, P. (1997) Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337, 677-680.CrossRefPubMedGoogle Scholar
  9. Girard, G. (1963) Immunity in plague. Results of 30 years of work on the “Pasteurella pestis Ev” (Girard and Robic) strain. Biol. Med. (Paris). 52, 631-731.Google Scholar
  10. Green, M., Rogers, D., Russell, P., Stagg, A.J., Bell, D.L., Eley, S.M., Titball, R.W. and Williamson, E.D. (1999) The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol. Med. Microbiol. 23, 107-113.Google Scholar
  11. Heath, D.G., Anderson, G.W., Jr., Mauro, J.M., Welkos, S.L., Andrews, G.P., Adamovicz, J. and Friedlander, A.M. (1998) Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine. 16, 1131-1137.CrossRefPubMedGoogle Scholar
  12. Heesemann, J., Sing, A. and Trulzsch, K. (2006) Yersinia’s stratagem: targeting innate and adaptive immune defense. Curr. Opin. Microbiol. 9, 55-61.CrossRefPubMedGoogle Scholar
  13. Igietseme, J.U., Eko, F.O., He, Q. and Black, C.M. (2004) Antibody regulation of T cell im-munity: implications for vaccine strategies against intracellular pathogens. Expert Rev. Vaccines. 3, 23-34.CrossRefGoogle Scholar
  14. Jones, S.M., Day, F., Stagg, A.J. and Williamson, E.D. (2000) Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four in-bred strains. Vaccine. 19, 358-366.CrossRefPubMedGoogle Scholar
  15. Kerschen, E.J., Cohen, D.A., Kaplan, A.M. and Straley, S.C. (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72, 4589-4602.CrossRefPubMedGoogle Scholar
  16. Lukaszewski, R.A., Kenny, D.J., Taylor, R., Rees, D.G., Hartley, M.G. and Oyston, P.C. (2005) Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macro-phages and neutrophils. Infect. Immun. 73, 7142-7150.CrossRefPubMedGoogle Scholar
  17. Marketon, M.M., DePaolo, R.W., DeBord, K.L., Jabri, B. and Schneewind, O. (2005) Plague bacteria target immune cells during infection. Science. 309, 1739-1741.CrossRefPubMedGoogle Scholar
  18. Meyer, K.F. (1970) Effectiveness of live or killed plague vaccines in man. Bull. World Health Organ. 42, 653-666.PubMedGoogle Scholar
  19. Nakajima, R. and Brubaker, R.R. (1993) Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 61, 23-31.PubMedGoogle Scholar
  20. Parent, M.A., Wilhelm, L.B., Kummer, L.W., Szaba, F.M., Mullarky, I.K. and Smiley, S.T. (2006) Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral de-fense against lethal pulmonary Yersinia pestis infection. Infect. Immun. 74, 3381-3386.CrossRefPubMedGoogle Scholar
  21. Parent, M.A., Berggren, K.N., Kummer, L.W., Wilhelm, L.B., Szaba, F.M., Mullarky, I.K. and Smiley, S.T. (2005) Cell-mediated protection against pulmonary Yersinia pestis infec-tion. Infect. Immun. 73, 7304-7310.CrossRefPubMedGoogle Scholar
  22. Perry, R.D. and Fetherston, J.D. (1997) Yersinia pestis-etiologic agent of plague. Clin. Micro-biol. Rev. 10, 35-66.Google Scholar
  23. Philipovskiy, A.V. and Smiley, S.T. (2007) Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect. Immun. In press.Google Scholar
  24. Pitt, M.L. (2004) Non-human primates as a model for pneumonic plague. Animals Models and Correlates of Protection for Plague Vaccines Workshop. Gaithersburg, MD, http://www.fda.gov/cber/minutes/plague101304t.pdf.
  25. Pujol, C., Grabenstein, J.P., Perry, R.D. and Bliska, J.B. (2005) Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmen-tation locus. Proc. Natl. Acad. Sci. USA. 102, 12909-12914.CrossRefPubMedGoogle Scholar
  26. Roggenkamp, A., Geiger, A.M., Leitritz, L., Kessler, A. and Heesemann, J. (1997) Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is de-pendent on polymorphism of V antigen. Infect. Immun. 65, 446-451.PubMedGoogle Scholar
  27. Sebbane, F., Lemaitre, N., Sturdevant, D.E., Rebeil, R., Virtaneva, K., Porcella, S.F. and Hinnebusch, B.J. (2006) Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc. Natl. Acad. Sci. USA. 103, 11766-11771.CrossRefPubMedGoogle Scholar
  28. Straley, S.C. and Cibull, M.L. (1989) Differential clearance and host-pathogen interactions of YopE- and YopK- YopL- Yersinia pestis in BALB/c mice. Infect. Immun. 57, 1200-1210.PubMedGoogle Scholar
  29. Titball, R.W. and Williamson, E.D. (2004) Yersinia pestis (plague) vaccines. Expert Opin. Biol. Ther. 4, 965-973.Google Scholar
  30. Trulzsch, K., Geginat, G., Sporleder, T., Ruckdeschel, K., Hoffmann, R., Heesemann, J. and Russmann, H. (2005) Yersinia outer protein P inhibits CD8 T cell priming in the mouse in-fection model. J. Immunol. 174, 4244-4251.PubMedGoogle Scholar
  31. Velan, B., Bar-Haim, E., Zauberman, A., Mamroud, E., Shafferman, A. and Cohen, S. (2006) Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect. Immun. 74, 6365-6376.CrossRefPubMedGoogle Scholar
  32. Viboud, G.I. and Bliska, J.B. (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59, 69-89.CrossRefPubMedGoogle Scholar
  33. Weeks, S., Hill, J., Friedlander, A. and Welkos, S. (2002) Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb. Pathog. 32, 227-237.CrossRefPubMedGoogle Scholar
  34. Williamson, E.D., Eley, S.M., Stagg, A.J., Green, M., Russell, P. and Titball, R.W. (1997) A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and pro-tects immunized animals against pneumonic plague. Vaccine. 15, 1079-1084.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Stephen T. Smiley
    • 1
  1. 1.Trudeau InstituteSaranac LakeUSA

Personalised recommendations